Circulating anti-Müllerian hormone and breast cancer risk: A study in ten prospective cohorts
<p>A strong positive association has been observed between circulating anti-Müllerian hormone (AMH), a biomarker of ovarian reserve, and breast cancer risk in three prospective studies. Confirming this association is important because of the paucity of biomarkers of breast cancer risk in preme...
Glavni autori: | Ge, W, Clendenen, TV, Afanasyeva, Y, Koenig, KL, Agnoli, C, Brinton, LA, Dorgan, JF, Eliassen, AH, Falk, RT, Hallmans, G, Hankinson, SE, Hoffman-Bolton, J, Key, TJ, Krogh, V, Nichols, HB, Sandler, DP, Schoemaker, MJ, Sluss, PM, Sund, M, Swerdlow, AJ, Visvanathan, K, Liu, M, Zeleniuch-Jacquotte, A |
---|---|
Format: | Journal article |
Izdano: |
Wiley
2018
|
Slični predmeti
-
Breast cancer risk prediction in women aged 35–50 years: impact of including sex hormone concentrations in the Gail model
od: Tess V. Clendenen, i dr.
Izdano: (2019-03-01) -
Anti-Müllerian hormone and risk of ovarian cancer in nine cohorts
od: Jung, S, i dr.
Izdano: (2017) -
Anti-Mullerian hormone and endometrial cancer: a multi-cohort study
od: Fortner, RT, i dr.
Izdano: (2017) -
Temporal reproducibility of IgG and IgM autoantibodies in serum from healthy women
od: T. V. Clendenen, i dr.
Izdano: (2022-04-01) -
Genetic Polymorphisms in Vitamin D Metabolism and Signaling Genes and Risk of Breast Cancer: A Nested Case-Control Study.
od: Tess V Clendenen, i dr.
Izdano: (2015-01-01)